Cite
HARVARD Citation
Curtis, J. et al. (2014). FRI0004 Randomization to Patient-Reported RAPID3 versus Physician-Based CDAI Tools for Prediction of Treatment Response and Assessment of Patient-Reported Outcomes in Rheumatoid Arthritis Patients Receiving Certolizumab Pegol: Results from the PREDICT Study. Annals of the rheumatic diseases. p. 382. [Online].